Shoogberry by Bulletproof Genetics
Indica strains × Sativa strains
Shoogberry, cultivated by Bulletproof Genetics, is a hybrid strain recognized for its balanced genetic profile, blending indica and sativa traits. This strain offers a distinct experience appealing to both recreational and medical consumers, stemming from meticulous breeding and modern cultivation techniques.
Appearance
Shoogberry buds are visually striking, characterized by their dense structure and often medium to large size. They are adorned with a frosty layer of trichomes, indicative of their potency, and display a rich green coloration frequently accented by purple hues. Bright orange pistils add a contrasting element to the overall aesthetic.
Aroma & Flavor
The aroma of Shoogberry is a complex bouquet, prominently featuring sweet, berry-like scents, complemented by subtle undertones of pine and spice. Upon consumption, the flavor profile echoes its aroma, delivering notes of ripe berries, often reminiscent of blueberries and raspberries, with additional layers of earthiness, herbal mint, and a hint of citrus that creates a refreshing finish.
Effects
Shoogberry is noted for delivering a balanced effect profile, stemming from its hybrid genetics. Users often report experiencing a sense of calm and euphoria, coupled with enhanced focus. This combination makes it suitable for various times of day and a range of consumer needs.
Terpenes & Cannabinoids
With a THC content typically ranging from 18% to 22%, Shoogberry provides a potent experience. CBD levels are generally below 1%, contributing to a subtle balancing effect. Key terpenes like Myrcene and Limonene are present, influencing the strain's aromatic and potential therapeutic qualities.
Origins & Lineage
Developed by Bulletproof Genetics, Shoogberry is the result of innovative hybridization techniques, carefully selecting parent strains to achieve a balanced blend of indica and sativa characteristics. The lineage is described as a mosaic, aiming to combine robust psychoactive effects with consistent therapeutic impacts.